Aceso Plasma
Aceso Plasma is dedicated to providing innovative plasma-based solutions for decontamination, air purification, and seed purification, with a focus on health, safety, and efficiency. Their mission is to develop effective, safe, and portable plasma devices to address various biological and environmental challenges.
Industries
Nr. of Employees
small (1-50)
Aceso Plasma
Products
Handheld low-temperature plasma generator
A portable device that generates oxygen-rich low-temperature plasma intended for rapid disinfection and topical treatment of wounds and for applications in surface, air, and seed decontamination.
Handheld low-temperature plasma generator
A portable device that generates oxygen-rich low-temperature plasma intended for rapid disinfection and topical treatment of wounds and for applications in surface, air, and seed decontamination.
Services
Use of low-temperature plasma processes to decontaminate equipment, vehicles, PPE and personnel surfaces against chemical and biological hazards without damaging materials or needing water.
Plasma-based air purification solutions designed to inactivate airborne bacteria and viruses without reliance on replaceable filters.
Plasma-based seed treatment processes to reduce phytopathogen load while maintaining seed viability for international seed shipments.
Laboratory and animal-model testing of plasma devices and treatments including in vitro bactericidal assays and in vivo burn wound studies with quantitative wound-healing endpoints.
Use of low-temperature plasma processes to decontaminate equipment, vehicles, PPE and personnel surfaces against chemical and biological hazards without damaging materials or needing water.
Plasma-based air purification solutions designed to inactivate airborne bacteria and viruses without reliance on replaceable filters.
Plasma-based seed treatment processes to reduce phytopathogen load while maintaining seed viability for international seed shipments.
Laboratory and animal-model testing of plasma devices and treatments including in vitro bactericidal assays and in vivo burn wound studies with quantitative wound-healing endpoints.
Expertise Areas
- Cold atmospheric plasma therapies
- Wound disinfection and healing
- Surface and equipment decontamination
- Air disinfection systems
Key Technologies
- Cold atmospheric plasma
- Oxygen plasma generation
- Low-temperature portable plasma generators
- Plasma spray/torch techniques
News & Updates
Burn wound healing can be significantly delayed by infection leading to increased morbidity and hypertrophic scarring. An optimal antimicrobial agent would have the ability to kill bacteria without negatively affecting the host skin cells that are required for healing. Currently available products provide antimicrobial coverage, but may also cause reductions in cell proliferation and migration. Cold atmospheric plasma is a partially ionized gas that can be produced under atmospheric pressure at room temperature. In this study a novel handheld Aceso Plasma Generator was used to produce and test Aceso Cold Plasma (ACP) in vitro and in vivo. ACP showed a potent ability to eliminate bacterial load in vitro for a number of different species. Deep partial-thickness and full-thickness wounds that were treated with ACP after burning, after excision, after autografting, and at days 5, 7, and 9 did not show any negative effects on their wound healing trajectories. On par with in vitro analysis, bioburden was decreased in treated wounds vs. control. In addition, metrics of hypertrophic scar such as dyschromia, elasticity, trans-epidermal water loss (TEWL), and epidermal and dermal thickness were the same between the two treatment groups. It is likely that ACP can be used to mitigate the risk of bacterial infection during the phase of acute burn injury while patients await surgery for definitive closure. It may also be useful in treating wounds with delayed re-epithelialization that are at risk for infection and hypertrophic scarring. A handheld cold plasma device will be useful in treating all manner of wounds and surgical sites in order to decrease bacterial burden in an efficient and highly effective manner without compromising wound healing.
Burn wound healing can be significantly delayed by infection leading to increased morbidity and hypertrophic scarring. An optimal antimicrobial agent would have the ability to kill bacteria without negatively affecting the host skin cells that are required for healing. Currently available products provide antimicrobial coverage, but may also cause reductions in cell proliferation and migration. Cold atmospheric plasma is a partially ionized gas that can be produced under atmospheric pressure at room temperature. In this study a novel handheld Aceso Plasma Generator was used to produce and test Aceso Cold Plasma (ACP) in vitro and in vivo. ACP showed a potent ability to eliminate bacterial load in vitro for a number of different species. Deep partial-thickness and full-thickness wounds that were treated with ACP after burning, after excision, after autografting, and at days 5, 7, and 9 did not show any negative effects on their wound healing trajectories. On par with in vitro analysis, bioburden was decreased in treated wounds vs. control. In addition, metrics of hypertrophic scar such as dyschromia, elasticity, trans-epidermal water loss (TEWL), and epidermal and dermal thickness were the same between the two treatment groups. It is likely that ACP can be used to mitigate the risk of bacterial infection during the phase of acute burn injury while patients await surgery for definitive closure. It may also be useful in treating wounds with delayed re-epithelialization that are at risk for infection and hypertrophic scarring. A handheld cold plasma device will be useful in treating all manner of wounds and surgical sites in order to decrease bacterial burden in an efficient and highly effective manner without compromising wound healing.